{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:00:39Z","timestamp":1783652439596,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["IN-NL-988-5952"],"award-info":[{"award-number":["IN-NL-988-5952"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015383","name":"Stichting voor Lever- en Maag-Darm Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejim.2022.11.012","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T07:45:23Z","timestamp":1668411923000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980\u20132020"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5435-9906","authenticated-orcid":false,"given":"D.P.C.","family":"van der Spek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.K.","family":"Katwaroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"van Kleef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7687-4036","authenticated-orcid":false,"given":"S.","family":"Brakenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"de Knegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10003","key":"10.1016\/j.ejim.2022.11.012_bib0001","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"issue":"9859","key":"10.1016\/j.ejim.2022.11.012_bib0002","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study","volume":"380","author":"Lozano","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejim.2022.11.012_bib0003","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2016.08.013","article-title":"Time trends of chronic HBV infection over prior decades - a global analysis","volume":"66","author":"Ott","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2022.11.012_bib0004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic Hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ejim.2022.11.012_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/hep.30246","article-title":"Advancing age and comorbidity in a US insured population-based cohort of patients with chronic Hepatitis B","volume":"69","author":"Nguyen","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejim.2022.11.012_bib0006","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/apt.15867","article-title":"Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B","volume":"52","author":"Oh","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ejim.2022.11.012_bib0007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000511585","article-title":"Increasing age and nonliver comorbidities in patients with chronic Hepatitis B in Taiwan: a nationwide population-based analysis","volume":"39","author":"Tseng","year":"2021","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.ejim.2022.11.012_bib0008","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000515854","article-title":"Characteristics and healthcare costs in the aging Hepatitis B population of Japan: a nationwide real-world analysis","volume":"40","author":"Yotsuyanagi","year":"2022","journal-title":"Dig Dis"},{"issue":"3","key":"10.1016\/j.ejim.2022.11.012_bib0009","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/sjg.SJG_447_18","article-title":"Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia","volume":"25","author":"Sanai","year":"2019","journal-title":"Saudi J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejim.2022.11.012_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/hep.30833","article-title":"An aging population of chronic Hepatitis B with increasing comorbidities: a territory-wide study from 2000 to 2017","volume":"71","author":"Wong","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ejim.2022.11.012_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41424-018-0007-6","article-title":"Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000-2015","volume":"9","author":"Liu","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejim.2022.11.012_bib0012","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hep.30857","article-title":"Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic Hepatitis B","volume":"71","author":"Choi","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejim.2022.11.012_bib0013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/gut.2008.157735","article-title":"Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B","volume":"58","author":"Wong","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ejim.2022.11.012_bib0014","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.012_bib0015","unstructured":"HBV Richtsnoer. HCC Surveillance [Available from: https:\/\/www.hbvrichtsnoer.nl\/hcc-surveillance\/."},{"issue":"4","key":"10.1016\/j.ejim.2022.11.012_bib0016","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/apt.13488","article-title":"Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B","volume":"43","author":"Li","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ejim.2022.11.012_bib0017","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2022.11.012_bib0018","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.ejim.2022.11.012_bib0019","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2022.11.012_bib0020","series-title":"Hoeveel mensen met een migratieachtergrond wonen in Nederland?","author":"CBS (Centraal Bureau voor Statistiek)","year":"2022"},{"issue":"6","key":"10.1016\/j.ejim.2022.11.012_bib0021","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic Hepatitis B. Time for an individualised approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ejim.2022.11.012_bib0022","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2021.04.015","article-title":"Decrease in viral hepatitis diagnoses during the COVID-19 pandemic in the Netherlands","volume":"77","author":"Sonneveld","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2022.11.012_bib0023","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2468-1253(20)30307-1","article-title":"Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis","volume":"6","author":"Tan","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ejim.2022.11.012_bib0024","article-title":"Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B","volume":"3","author":"van Kleef","year":"2021","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.ejim.2022.11.012_bib0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"European Association for the Study of the Liver","year":"2021","journal-title":"J Hepatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522004022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522004022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:37:45Z","timestamp":1760607465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522004022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"alternative-id":["S0953620522004022"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.11.012","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980\u20132020","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}